Skip to content
  • Tuesday, 27 October 2026
  • 7:50 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Bayer Commits $2.2bn to Establish State-of-the-Art Pharmaceutical Manufacturing Facility at New Albany International Business Park in Ohio
Pharmaceutical R&D

Bayer Commits $2.2bn to Establish State-of-the-Art Pharmaceutical Manufacturing Facility at New Albany International Business Park in Ohio

Teuku Ryan Oct 6, 2026 0

Life sciences giant Bayer has announced a monumental $2.2bn capital investment dedicated to the construction of a cutting-edge pharmaceutical manufacturing…

Read More
Pharmaceutical R&D

Bayer Secures FDA Accelerated Approval for Hyrnuo in Frontline HER2-Mutant Non-Small Cell Lung Cancer

Teuku Ryan Sep 11, 2026 0

Bayer has achieved a significant regulatory milestone with the US Food and Drug Administration (FDA) granting accelerated approval for its…

Read More
Pharmaceutical R&D

Bayer Acquires Perfuse Therapeutics for Up to $2.45 Billion to Bolster Ophthalmology Pipeline with Novel Endothelin Receptor Antagonist

Teuku Ryan May 6, 2026 0

Bayer AG is set to significantly expand its presence in the ophthalmology market with the acquisition of Perfuse Therapeutics, a…

Read More
New Two-Component Dark Matter Model Provides Unified Solution to Galaxy Density and Gravitational Lensing ParadoxesBreaking the Neuroimaging Time Barrier: Johns Hopkins Researchers Unveil CloudScope to Monitor Brain Disease Over 24 HoursUndergraduate Research Breaks New Ground in Dark Matter Detection with Compact Cavity ExperimentTWiV 1289: Building a better hepatitis B trap
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ